Citation Impact
Citing Papers
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
2008 Standout
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
Cushing’s Syndrome Due to Ectopic Corticotropin Secretion: Twenty Years’ Experience at the National Institutes of Health
2005
A New Triggering Receptor Expressed on Myeloid Cells (Trem) Family Member, Trem-Like 4, Binds to Dead Cells and Is a DNAX Activation Protein 12-Linked Marker for Subsets of Mouse Macrophages and Dendritic Cells
2009 StandoutNobel
Contrasting Properties of Hypoxia-Inducible Factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-Associated Renal Cell Carcinoma
2005 StandoutNobel
Cancer statistics, 2017
2017 Standout
Inherited pancreatic endocrine tumor syndromes: Advances in molecular pathogenesis, diagnosis, management, and controversies
2008
Inflammation and cancer
2002 StandoutNature
Combined chemokine and cytokine gene transfer enhances antitumor immunity
1996
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
2011 Standout
Chemokines: agents for the immunotherapy of cancer?
2002
Chemokines — Chemotactic Cytokines That Mediate Inflammation
1998 Standout
Molecular basis of the VHL hereditary cancer syndrome
2002 StandoutNobel
Cushing's syndrome
2015 Standout
Phaeochromocytoma
2005 Standout
Renal-Cell Carcinoma
1996 Standout
CTLA-4: new insights into its biological function and use in tumor immunotherapy
2002 StandoutNobel
Human gene therapy comes of age
1992 Nature
Renal Tumors in the Birt-Hogg-Dubé Syndrome
2002
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
1996 StandoutNature
Involvement of chemokine receptors in breast cancer metastasis
2001 StandoutNature
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
2007 Standout
Gene therapy for cancer
1994
The von Hippel-Lindau Tumor Suppressor Protein Is Required for Proper Assembly of an Extracellular Fibronectin Matrix
1998 StandoutNobel
von Hippel-Lindau disease
2003 Standout
Peritonectomy Procedures
1995 Standout
VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400
2008 StandoutNobel
Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression
2012 StandoutNobel
Mechanisms of relapse for colorectal cancer: Implications for intraperitoneal chemotherapy
1991
Chemokines and their role in tumor growth and metastasis
1998
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
2007 Standout
Cushing's syndrome
2006 Standout
Creation of human tumour cells with defined genetic elements
1999 StandoutNature
Angiogenesis as a therapeutic target
2005 StandoutNature
PERCUTANEOUS RADIO FREQUENCY ABLATION OF SMALL RENAL TUMORS: INITIAL RESULTS
2002
Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer
1997 StandoutNobel
A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability.
1992
Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.
1992 StandoutNobel
Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer.
1995
Expression of nm23 in cell lines derived from patients with metastatic renal cell carcinoma.
1995
Cross-presentation of glycolipid from tumor cells loaded with α-galactosylceramide leads to potent and long-lived T cell–mediated immunity via dendritic cells
2007 StandoutNobel
THE RELATIONSHIP BETWEEN RENAL TUMOR SIZE AND METASTASES IN PATIENTS WITH VON HIPPEL-LINDAU DISEASE
2004
CTLA-4 blockade synergizes with tumor-derived granulocyte– macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma
1998 StandoutNobel
Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma
1999 StandoutNobel
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
1993 Standout
Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
1996
Elucidating the Autoimmune and Antitumor Effector Mechanisms of a Treatment Based on Cytotoxic T Lymphocyte Antigen-4 Blockade in Combination with a B16 Melanoma Vaccine
2001 StandoutNobel
RENAL CANCER IN FAMILIES WITH HEREDITARY RENAL CANCER: PROSPECTIVE ANALYSIS OF A TUMOR SIZE THRESHOLD FOR RENAL PARENCHYMAL SPARING SURGERY
1999
Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma
2008 StandoutNobel
Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells.
1992
The Diagnosis and Differential Diagnosis of Cushing’s Syndrome and Pseudo-Cushing’s States
1998
Thyroid Cancer Gender Disparity
2010
Kinase requirements in human cells: III. Altered kinase requirements inVHL−/− cancer cells detected in a pilot synthetic lethal screen
2008 StandoutNobel
DIFFERENTIAL DIAGNOSIS AND MANAGEMENT OF CUSHING'S SYNDROME
1996
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
pVHL 19 is a biologically active product of the von Hippel–Lindau gene arising from internal translation initiation
1998 StandoutNobel
VHL-mediated hypoxia regulation of cyclin D1 in renal carcinoma cells.
2002
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
1996 StandoutNobel
Production of high-titer helper-free retroviruses by transient transfection.
1993 StandoutNobel
Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells
1993 StandoutScienceNobel
Potential role of natural killer cells in controlling tumorigenesis by human T-cell leukemia viruses
1995
PREVALENCE, MORPHOLOGY AND BIOLOGY OF RENAL CELL CARCINOMA IN VON HIPPEL-LINDAU DISEASE COMPARED TO SPORADIC RENAL CELL CARCINOMA
1998
Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of β cells
2007 StandoutNobel
Prevalence of Microscopic lesions in Grossly Normal Renal Parenchyma from Patients with von Hippel-Lindau Disease, Sporadic Renal Cell Carcinoma and No Renal Disease: Clinical Implications
1995
CTLA-4-Mediated Inhibition in Regulation of T Cell Responses: Mechanisms and Manipulation in Tumor Immunotherapy
2001 StandoutNobel
A simplified system for generating recombinant adenoviruses
1998 Standout
Enhancement of Antitumor Immunity by CTLA-4 Blockade
1996 StandoutScienceNobel
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
1998 Standout
Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines
1999
Role ofVHLGene Mutation in Human Cancer
2004 StandoutNobel
Ectopic ACTH syndrome
2007
Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells
2005 StandoutNobel
Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Vaccines Induces Rejection of Subcutaneous and Metastatic Tumors Accompanied by Autoimmune Depigmentation
1999 StandoutNobel
Demonstration of a Rational Strategy for Human Prostate Cancer Gene Therapy
1994
Works of Gitie Jaffe being referenced
Flow cytometry and Zollinger-Ellison syndrome: Relationship to clinical course
1993
Histologic changes induced by intraperitoneal chemotherapy with 5-fluorouracil and mitomycin c in patients with peritoneal carcinomatosis from cystadenocarcinoma of the colon or appendix
1990
Corticotropin-secreting carcinoid tumors of the thymus: diagnostic unreliability of thymic venous sampling.
1992
Characterization of the Renal Pathology of a Familial Form of Renal Cell Carcinoma Associated With Von Hippel-Lindau Disease: Clinical and Molecular Genetic Implications
1995
RET Expression in Papillary Thyroid Cancer from Patients Irradiated in Childhood for Benign Conditions
2002
Cytokine secretion by genetically modified nonimmunogenic murine fibrosarcoma. Tumor inhibition by IL-2 but not tumor necrosis factor
1993
Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumors
1991
Loss of Heterozygosity Occurs Centromeric to RB Without Associated Abnormalities in the Retinoblastoma Gene in Tumors from Patients with Metastatic Renal Cell Carcinoma
1995